• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
  

PubMed=11261825; DOI=10.1023/A:1006461422273
Santner S.J., Dawson P.J., Tait L., Soule H.D., Eliason J.F., Mohamed A.N., Wolman S.R., Heppner G.H., Miller F.R.
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
Breast Cancer Res. Treat. 65:101-110(2001)

PubMed=15375546; DOI=10.3892/ijo.25.4.961
Peng X.-J., Yun D.-R., Christov K.
Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Int. J. Oncol. 25:961-971(2004)

PubMed=20169162; DOI=10.1371/journal.pone.0009201; PMCID=PMC2821407
Kadota M., Yang H.H., Gomez B.P., Sato M., Clifford R.J., Meerzaman D., Dunn B.K., Wakefield L.M., Lee M.P.
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PLoS ONE 5:E9201-E9201(2010)

PubMed=24262153; DOI=10.1016/j.jprot.2013.11.006; PMCID=PMC3920745
Yen T.-Y., Haste N., Timpe L.C., Litsakos-Cheung C., Yen R., Macher B.A.
Using a cell line breast cancer progression system to identify biomarker candidates.
J. Proteomics 96:173-183(2014)